Both characteristics – tumor stage and low CD10 expression – seem to be necessary for predicting relapse, which highlights the importance of assessing intrinsic DCIS properties as well as the surrounding microenvironment. The gene discussed is MME; the disease is ductal breast carcinoma in situ.